Di Yi Jun Yi Da Xue Xue Bao
January 2002
Gemcitabine is a newly developed drug for treating advanced non-small cell lung cancer (NSCLC). Adopting a treatment protocol combining gemcitabine and carboplatin, we succeeded in the management of 1 case of advanced NSCLC, and in this report the clinical status and findings by electron bronchoscopy of the patient were reported.
View Article and Find Full Text PDF